0000899243-21-007774.txt : 20210223
0000899243-21-007774.hdr.sgml : 20210223
20210223141928
ACCESSION NUMBER: 0000899243-21-007774
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210221
FILED AS OF DATE: 20210223
DATE AS OF CHANGE: 20210223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sprague John M
CENTRAL INDEX KEY: 0001730056
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 21664570
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-21
0
0001492674
T2 Biosystems, Inc.
TTOO
0001730056
Sprague John M
101 HARTWELL AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Financial Officer
Common Stock
2021-02-21
4
M
0
10000
A
40735
D
Common Stock
2021-02-23
4
S
0
5250
2.04
D
35485
D
Restricted Stock Units
2021-02-21
4
M
0
10000
0.00
D
Common Stock
10000
10000
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Includes 6,812 shares acquired under the Issuer's employee stock purchase plan ("ESPP") on May 15, 2020 and 1,701 shares acquired under the ESPP on November 15, 2020.
The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
On February 21, 2019 the reporting person was granted 30,000 RSU's that vest in three equal annual installments beginning on February 21, 2020.
/s/ John Sprague, Attorney-in-fact
2021-02-23